JNK downregulation improves olanzapine-induced insulin resistance by suppressing IRS1 Ser307 phosphorylation and reducing inflammation.

MLA

Li, Huqun, et al. “JNK Downregulation Improves Olanzapine-Induced Insulin Resistance by Suppressing IRS1 Ser307 Phosphorylation and Reducing Inflammation.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 142, Oct. 2021, p. 112071. EBSCOhost, https://doi.org/10.1016/j.biopha.2021.112071.

APA

Li, H., Wang, C., Zhao, J., & Guo, C. (2021). JNK downregulation improves olanzapine-induced insulin resistance by suppressing IRS1 Ser307 phosphorylation and reducing inflammation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 142, 112071. https://doi.org/10.1016/j.biopha.2021.112071

Chicago

Li, Huqun, Chongshu Wang, Jiefang Zhao, and Cuilian Guo. 2021. “JNK Downregulation Improves Olanzapine-Induced Insulin Resistance by Suppressing IRS1 Ser307 Phosphorylation and Reducing Inflammation.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 142 (October): 112071. doi:10.1016/j.biopha.2021.112071.